The proof of concept for the device came out of collaboration between Sailesh’s former group at Microsoft Research, and David’s lab at Washington University at St. Louis. It generated a tremendous amount of excitement in the medical community as a potential successor to the “stethoscope”, but one that is a lot more powerful. Whenever medical professionals saw a demo of the device, they wanted to buy it. Since it is hard to sell a research prototype, Sailesh and David decided to incorporate Mobisante in December 2009 to create a commercial product based on the original idea.
Several community clinics quickly got behind the effort and provided the initial seed funds. Emergency physicians, surgeons, top academic medical centers, and community clinics piloted the beta version of the device and provided valuable feedback to help improve it. WRF Capital invested in the company in November 2010. The first product, the MobiUS SP1 system, was cleared by the FDA in January 2011 and launched in the USA market in October 2011. This represents what is probably the shortest time frame for a medical device to move from concept to a commercial product. The MobiUS SP1 system also became the first cellphone-based diagnostic device to be cleared by the FDA.